Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Long-Acting Injection”

Showing 16 of 0 results

Large-scale testing (Phase 3)Study completedNCT05896748
What this trial is testing

Study to Assess the Effects of Cabotegravir (CAB) and Rilpivirine (RPV) Long-Acting (LA) Injections Following Sub-cutaneous (SC) Administration Compared With Intramuscular (IM) Administration in Adult Participants Living With Human Immunodeficiency Virus (HIV-1) Infection in the FLAIR Study

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1)
ViiV Healthcare 94
Post-approval studies (Phase 4)Ended earlyNCT01267825
What this trial is testing

CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial

Who this might be right for
Disc HerniationLumbosacral Radiculopathy
Montefiore Medical Center 1
Early research (Phase 1)Study completedNCT03527186
What this trial is testing

Comparative Bioavailability of Risperidone

Who this might be right for
Schizophrenia
Rovi Pharmaceuticals Laboratories 81
Large-scale testing (Phase 3)Study completedNCT00246246
What this trial is testing

A Randomized, Open-label Trial of Long-acting Injectable Risperidone Versus Oral Antipsychotic Medication in Patients With Bipolar Disorder

Who this might be right for
Bipolar Disorder
Janssen-Ortho Inc., Canada 48
Large-scale testing (Phase 3)Study completedNCT01258920
What this trial is testing

Paliperidone Palmitate in Japanese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Janssen Pharmaceutical K.K. 201
Early research (Phase 1)Looking for participantsNCT07093580
What this trial is testing

Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants

Who this might be right for
Healthy Participants
Shionogi 98
Post-approval studies (Phase 4)Study completedNCT00539071
What this trial is testing

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 160
Not applicableNot Yet RecruitingNCT06704204
What this trial is testing

Long-acting Injectable Antiretroviral Treatment to Improve HIV Treatment Among Justice-involved Persons Being Released to the Community

Who this might be right for
HIV
The Miriam Hospital 20
Not applicableNot Yet RecruitingNCT07570875
What this trial is testing

Evaluating the Impact of Ketogenic Therapy on Symptom Severity and Metabolic Side Effect Profile Among Individuals Living With Bipolar Disorder in A Rural Southern Catchment Area

Who this might be right for
Bipolar Disorder
University of Alabama at Birmingham 100
Early research (Phase 1)Study completedNCT01593046
What this trial is testing

Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 43
Large-scale testing (Phase 3)Study completedNCT00589914
What this trial is testing

Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 1,221
Post-approval studies (Phase 4)Study completedNCT01136772
What this trial is testing

A Comparison of Long-acting Injectable Medications for Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
New York State Psychiatric Institute 311
Early research (Phase 1)Study completedNCT02547870
What this trial is testing

Evaluate the Pharmacokinetic Effects of Different Storage Conditions for a Long-Acting Nanosuspension of Rilpivirine on Pharmacokinetics

Who this might be right for
Human Immunodeficiency Virus Type 1
Janssen Infectious Diseases BVBA 61
Large-scale testing (Phase 3)Study completedNCT00253136
What this trial is testing

The Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia

Who this might be right for
SchizophreniaPsychotic Disorders
Janssen, LP 458
Post-approval studies (Phase 4)Study completedNCT00216528
What this trial is testing

Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres

Who this might be right for
Schizophrenia
Janssen Korea, Ltd., Korea 527
Not applicableStudy completedNCT00423228
What this trial is testing

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Who this might be right for
Moderate Alzheimer's Disease
Debiopharm International SA 228

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation